p-Toluenesulfonic acid monohydrate → Travoprost

HRID 517375

反応式

HRID 517375 の反応式
C([Si](CC)(CC)[O:4][C@@H:5]1[CH2:9][C@H:8]([O:10][Si](CC)(CC)CC)[C@H:7]([CH2:18]/[CH:19]=[CH:20]\[CH2:21][CH2:22][CH2:23][C:24]([O:26][CH:27]([CH3:29])[CH3:28])=[O:25])[C@H:6]1/[CH:30]=[CH:31]/[C@@H:32]([O:45][Si](CC)(CC)CC)[CH2:33][O:34][C:35]1[CH:40]=[CH:39][CH:38]=[C:37]([C:41]([F:44])([F:43])[F:42])[CH:36]=1)C.O.C1(C)C=CC(S(O)(=O)=O)=CC=1>CC(C)=O.O>[OH:4][C@@H:5]1[CH2:9][C@H:8]([OH:10])[C@H:7]([CH2:18]/[CH:19]=[CH:20]\[CH2:21][CH2:22][CH2:23][C:24]([O:26][CH:27]([CH3:29])[CH3:28])=[O:25])[C@H:6]1/[CH:30]=[CH:31]/[C@@H:32]([OH:45])[CH2:33][O:34][C:35]1[CH:40]=[CH:39][CH:38]=[C:37]([C:41]([F:42])([F:43])[F:44])[CH:36]=1

参加物

5

反応物 2

HCID 521998p-Toluenesulfonic acid monohydrateHCID 131733340(Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-bis((triethylsilyl)oxy)-2-((R,E)-3-((triethylsilyl)oxy)-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate

生成物 1

HCID 5282226Travoprost収率 92.7%

試薬・触媒・溶媒 2

HCID 180Acetone溶媒HCID 962Water溶媒

実験手順

The product of Example 11 (0.8 g) was dissolved in 10 ml acetone and 2 ml water, followed by addition of 0.1 g p-toluenesulfonic acid monohydrate. The reaction solution was stirred at room temperature for 1 hour and concentrated until two separate layers were observed. 30 ml ethyl acetate was added for extraction and phase separation. The organic layer was washed with saturated sodium bicarbonate solution and brine, dried over anhydrous magnesium sulfate, and subjected to vacuum evaporation for removal of the solvent until dryness. The crude Travoprost was purified by column chromatography and then concentrated under reduced pressure to provide 0.44 g of Travoprost. UPLC (ACQUITY UPLC HSS C18) analysis of the product showed that no isomer and impurities were detectable and the purity was higher then 99.9%.

後処理

  1. concentrationconcentrated until two
  2. customseparate layers
  3. addition30 ml ethyl acetate was added for extraction and phase separation
  4. washThe organic layer was washed with saturated sodium bicarbonate solution and brine
  5. dry with materialdried over anhydrous magnesium sulfate
  6. customsubjected to vacuum evaporation for removal of the solvent until dryness
  7. customThe crude Travoprost was purified by column chromatography
  8. concentrationconcentrated under reduced pressure

出典と根拠

ORDレコード
ord-4679549259c54a2a943f38a28c952546
出典データセット
uspto-grants-2015_08
特許番号
US09115109B2

関連ノート

読み込み中…